Piramal Pharma Limited

In 2025, Piramal Pharma Limited reported total carbon emissions of approximately 618.5 million kg CO2e. This figure includes Scope 1 emissions of about 32.3 million kg CO2e, Scope 2 emissions of approximately 66.1 million kg CO2e, and Scope 3 emissions amounting to about 491.1 million kg CO2e. The company has set ambitious targets to reduce its greenhouse gas emissions, committing to a 42% reduction in absolute Scope 1 and Scope 2 emissions by FY2030, using FY2022 as the baseline. Additionally, Piramal aims for a 25% reduction in absolute Scope 3 emissions within the same timeframe.

Piramal Pharma Limited has applied for the Science Based Targets initiative (SBTi) to align its emissions reduction goals with the 1.5°C decarbonisation pathway. The targets encompass emissions from purchased goods and services, fuel and energy-related activities, upstream transportation and distribution, and the use of sold products. These commitments reflect the company's dedication to sustainability and its proactive approach to addressing climate change.